Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.39
+0.89 (5.39%)
At close: Mar 27, 2026

HKG:1681 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4172,9672,5902,3402,045
Revenue Growth (YoY)
15.17%14.56%10.71%14.43%16.65%
Cost of Revenue
750.24725.13668.44576.74517.32
Gross Profit
2,6672,2421,9221,7631,527
Selling, General & Admin
1,5181,2931,1681,094900
Other Operating Expenses
-52.65-17.55-59.45-14.47-14.8
Operating Expenses
1,4651,2671,0961,048867.15
Operating Income
1,202974.99825.92715.41660.18
Interest Expense
-4.36-24.89-21.26-10.93-12.91
Interest & Investment Income
-88.368.9252.4139.25
Earnings From Equity Investments
-1.6-0.07---
Currency Exchange Gain (Loss)
--17.88-9.03-9.2811.33
EBT Excluding Unusual Items
1,1961,020864.55747.61697.85
Gain (Loss) on Sale of Assets
--0.35-0.85-1.22-1.99
Pretax Income
1,1961,020863.7746.39695.86
Income Tax Expense
107.29102.7377.1562.7108.74
Earnings From Continuing Operations
1,089917.37786.55683.7587.12
Minority Interest in Earnings
-11.07-6.92-2.02-0.793.06
Net Income
1,078910.46784.53682.91590.17
Net Income to Common
1,078910.46784.53682.91590.17
Net Income Growth
18.41%16.05%14.88%15.71%18.32%
Shares Outstanding (Basic)
849821791791802
Shares Outstanding (Diluted)
856832799792805
Shares Change (YoY)
2.82%4.12%0.91%-1.58%-1.54%
EPS (Basic)
1.271.110.990.860.74
EPS (Diluted)
1.261.090.980.860.73
EPS Growth
15.60%11.22%13.95%17.81%19.67%
Free Cash Flow
-977.99766.41896.09627.29
Free Cash Flow Per Share
-1.180.961.130.78
Dividend Per Share
-0.5640.4080.2650.244
Dividend Growth
-38.03%53.92%8.58%3.66%
Gross Margin
78.05%75.56%74.19%75.35%74.70%
Operating Margin
35.18%32.86%31.89%30.58%32.29%
Profit Margin
31.55%30.68%30.29%29.19%28.86%
Free Cash Flow Margin
-32.96%29.59%38.30%30.68%
EBITDA
1,2591,032897.51785.89728.71
EBITDA Margin
36.84%34.77%34.65%33.59%35.64%
D&A For EBITDA
56.7356.7371.5870.4868.53
EBIT
1,202974.99825.92715.41660.18
EBIT Margin
35.18%32.86%31.89%30.58%32.29%
Effective Tax Rate
8.97%10.07%8.93%8.40%15.63%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.